sofpironium topical (Pending FDA Approval)

Brand and Other Names:
  • Print
Sections

Dosing & Uses

Hyperhidrosis

Pending FDA approval for topical treatment of primary axillary hyperhidrosis

Next:

Pharmacology

Mechanism of Action

Aanticholinergic/antimuscarinic drug that blocks sweating at the gland by binding to the receptor and thereby blocking the sweat signal

Previous
Next:

Images

Pricing & Images are not currently available for this monograph.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.